Proteon Therapeutics Inc Logo Image

Proteon Therapeutics Inc

Proteon Therapeutics Inc has reached its limit for report views.

Please check back to see if Proteon Therapeutics Inc has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report and Form 10K

Proteon Therapeutics Inc
Order Free Hardcopy

You can request a free hardcopy of this report mailed to you by clicking the button below.

Add Annual Report

Archived Annual Reports

  • Proteon Therapeutics Inc
  • Proteon Therapeutics Inc

About Proteon Therapeutics Inc

11-50 Employees
Based in Waltham, Massachusetts

Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular diseases. It develops vonapanitase, a recombinant human elastase, which is in a Phase III clinical trials for the treatment of radiocephalic arteriovenous fistula to enable hemodialysis; has completed a Phase I/II clinical trials for the treatment of patients undergoing surgical placement of an arteriovenous graft; and is in a Phase I clinical trials for the treatment of symptomatic peripheral artery diseases.

Ticker:
PRTO
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol